US20050278013A1 - Method for endovascular bypass stent graft delivery - Google Patents

Method for endovascular bypass stent graft delivery Download PDF

Info

Publication number
US20050278013A1
US20050278013A1 US10/891,397 US89139704A US2005278013A1 US 20050278013 A1 US20050278013 A1 US 20050278013A1 US 89139704 A US89139704 A US 89139704A US 2005278013 A1 US2005278013 A1 US 2005278013A1
Authority
US
United States
Prior art keywords
needle
stent graft
vessel
bypass
guidewire
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/891,397
Inventor
Matthew Rust
Prema Ganesan
Curtis Hanson
Jack Chu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Vascular Inc
Original Assignee
Medtronic Vascular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Vascular Inc filed Critical Medtronic Vascular Inc
Priority to US10/891,397 priority Critical patent/US20050278013A1/en
Assigned to MEDTRONIC VASCULAR, INC. reassignment MEDTRONIC VASCULAR, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HANSON, CURTIS, RUST, MATTHEW, CHU, JACK, GANESAN, PREMA
Priority to PCT/US2005/015576 priority patent/WO2005117751A1/en
Publication of US20050278013A1 publication Critical patent/US20050278013A1/en
Priority to US11/464,036 priority patent/US7815656B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A61B17/12118Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/064Blood vessels with special features to facilitate anastomotic coupling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3403Needle locating or guiding means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • A61B2017/00247Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • A61B2017/00252Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/89Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/061Blood vessels provided with means for allowing access to secondary lumens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/072Encapsulated stents, e.g. wire or whole stent embedded in lining

Definitions

  • This invention relates generally to biomedical devices that are used for treating vascular conditions. More specifically, the invention relates to a method for endovascular bypass stent graft delivery.
  • Stents are generally cylindrical-shaped devices that are radially expandable to hold open a segment of a vessel or other anatomical lumen after implantation into the body lumen.
  • Expandable stents generally are conveyed to the area to be treated on balloon catheters or other expandable devices.
  • the stent is positioned in a compressed configuration along the delivery device, for example crimped onto a balloon that is folded or otherwise wrapped about a guidewire that is part of the delivery device.
  • the stent is positioned across the lesion, it is expanded by the delivery device, causing the diameter to expand.
  • a self-expanding stent commonly a sheath is retracted, allowing expansion of the stent.
  • Stents may be used in conjunction with a graft.
  • a graft When the graft is used to deliver drugs or other therapeutic agents for medical therapeutic applications, 100% coverage of the portion of the vessel in direct contact with the graft is possible.
  • the graft component of a stent graft may also aid in minimizing thrombosis, preventing embolic events, and minimizing contact between the fissured plaque and the hematological elements in the bloodstream.
  • the graft component makes the device suitable for use in treating aneurysms.
  • An aneurysm is a bulge or sac that forms in the wall of a blood vessel. The force of normal blood pressure in the aneurysm may cause the vessel to rupture. Aneurysms result from many causes that weaken the vessel wall, including but not limited to heredity, trauma, or disease.
  • a number of methods and devices have been developed for treating aneurysms.
  • a standard treatment is surgery, which is performed to bypass the section of the vessel where the aneurysm has formed.
  • An alternative treatment is a technique known as endovascular stent grafting.
  • a stent graft is placed inside the vessel affected by the aneurysm to bypass the weakened vessel wall, thereby preventing rupture of the aneurysm.
  • stent grafts are delivered to the area to be treated using balloon catheters or other expandable devices and may deliver one or more therapeutic agents.
  • stent grafts at the ostia of vessels has been difficult due to placement restrictions—placing a stent graft at an ostium requires that the stent graft be close to but not overlapping the ostium to maintain the desired blood flow between the main vessel and a branch vessel.
  • Another approach is to provide a fenestration in the side of a graft at the branching ostium, in some instances, a branching tube to seal to the branch has been proposed.
  • An exemplary approach is disclosed by Wisselink in U.S. Pat. No. 6,428,565.
  • the Wisselink reference requires customizing the stent graft to correspond to the vessel anatomy ensuring the seal between the graft devices.
  • One aspect according to the invention is a method of providing an endovascular bypass.
  • the method includes inserting an elastic, e.g. shape-memory, needle adjacent an ostium via a catheter and extending the needle through a branch vessel wall.
  • the needle is extended through an extravascular space and through a main vessel wall to create an opening.
  • a guidewire is delivered via the needle.
  • the needle is retracted, leaving the guidewire in place, and a bypass stent graft is inserted along the guidewire through the extravascular space between the branch vessel and the main vessel.
  • the bypass stent graft is expanded and the branch vessel occluded between the opening of the bypass stent graft in the branch vessel and the main vessel.
  • the method further includes inserting a main vessel stent graft in the main vessel proximate the opening of the bypass stent graft into the main vessel wall.
  • the system includes a catheter including a retractable elastic needle carried within the catheter and covered with a sheath, wherein when the needle is positioned adjacent the ostium in a branch vessel, the needle deploys into a predetermined shape and punctures through a sidewall of the branch vessel through the extravascular space and through a sidewall of the main vessel, a guidewire is delivered via the needle, and the needle is retracted to allow placement of a bypass stent graft.
  • Yet another aspect according to the invention provides a system for treating a vascular condition.
  • the system includes a catheter, a stent graft, and an elastic needle releasably carrying a guidewire disposed within the needle.
  • FIGS. 1A, 1B , 1 C, and 1 D are views of one embodiment of a needle assembly, in accordance with the present invention.
  • FIG. 2 is a view of one embodiment of a stent-graft assembly, in accordance with the present invention.
  • FIG. 3 is a flow chart illustrating the steps of a method for providing an endovascular bypass, in accordance with the present invention
  • FIGS. 4A, 4B , 4 C, 4 D, 4 E and 4 F are schematic cross sectional views of a vascular structure, illustrating in situ the steps of the method described in FIGS. 1A, 1B , 1 C, and 1 D;
  • FIGS. 5A and 5B are schematic cross sectional views of other embodiments of stent graft assemblies, in accordance with the present invention.
  • FIG. 6 is a schematic cross sectional view of a bypass of an ostium with a bypass stent graft and a main stent graft in accordance with one aspect of the present invention
  • FIG. 7 is a schematic cross sectional view of a bypass of the ostium of the common iliac artery with the internal and external branches of the artery with a bypass stent graft and a main stent graft in accordance with the present invention
  • FIG. 8 is a schematic cross sectional view of a bypass of the ostium of the aorta with the celiac artery and superior mesenteric artery with a bypass stent graft and a main stent graft in accordance with the present invention.
  • FIGS. 9A-9C are schematic cross sectional views of bypasses of arteries of the aortic arch with a bypass stent graft and a main stent graft in accordance with the present invention.
  • FIGS. 1A, 1B , 1 C and 1 D One embodiment of the invention comprises a needle system 100 as illustrated at FIGS. 1A, 1B , 1 C and 1 D.
  • the system may be used to treat a vascular condition.
  • needle system 100 may be used to treat an ostial encroaching aneurysm.
  • FIG. 1A illustrates needle system 100 prior to deployment.
  • Needle system 100 includes needle 110 carried within a retractable sheath 120 . Needle 110 and sheath 120 are delivered through a catheter 105 , which is shown only in FIG. 1A .
  • Needle 110 is a curved needle comprising a shape-memory material.
  • needle 110 comprises nitinol.
  • needle 110 comprises tantalum, MP35N alloy, platinum, titanium, a chromium-based alloy, a suitable biocompatible alloy, a suitable biocompatible polymer, or combinations thereof.
  • sheath 120 Prior to deployment, needle 110 is restrained in a substantially straight configuration by sheath 120 .
  • FIG. 1B illustrates needle system 100 during deployment. As shown, while sheath 120 is held stationary, the needle is extended, allowing needle 110 to partially resume its preset shape.
  • FIG. 1C illustrates needle system 100 in a deployed configuration. Needle 110 has assumed its preset shape-memory configuration. In one embodiment, the preset shape is an arc or curved shape.
  • Needle 110 is hollow with the internal diameter sized to carry a guidewire 130 within the needle, as seen in FIG. 1D .
  • the needle carries guidewire 130 .
  • guidewire 130 is delivered through needle 110 during or following positioning of the needle.
  • Catheter 105 may carry a stent graft and may be a system such as system 200 illustrated in FIG. 2 .
  • System 200 comprises a catheter 210 and a stent graft assembly 220 operably coupled to the catheter.
  • the coupling of stent graft assembly 220 to catheter 210 comprises any known technique for securing a stent graft to a delivery catheter.
  • the stent graft is crimped to the catheter, while in other examples, heat-sensitive adhesives are used.
  • the stent graft assembly 220 includes a stent framework 230 , an inner graft portion 240 , and an outer graft portion 250 .
  • the stent graft assembly delivers a therapeutic agent, in one embodiment.
  • Catheter 210 may include a balloon to expand the stent graft as well as increase the size of a conduit or pathway (as illustrated in FIG. 4D below) to make it easier to pass the stent graft, or it may include a sheath that retracts to allow expansion of a self-expanding stent. Both types of catheter are well known in the art.
  • Stent graft assembly 220 is shown coupled to catheter 210 for delivery within a vessel.
  • the balloon may be any known balloon, and in some embodiments, the balloon is a cutting balloon, in the event the conduit left by the needle is too small to pass the stent graft system.
  • Embodiments using a cutting balloon require that the stent graft assembly 220 is inserted only after the cutting balloon is removed from the area where deployment of the cutting balloon could impact upon deployment of the stent graft.
  • embodiments using a cutting balloon may require operation of at least two balloons—a first cutting balloon to expand the pathway created by a needle, and a second balloon to expand the stent graft.
  • a first cutting balloon to expand the pathway created by a needle
  • a second balloon to expand the stent graft.
  • the balloon operable to expand the stent graft assembly could be replaced by a self-expanding stent, as known.
  • the cutting balloon is expanded within the extravascular space to expand the pathway through the extravascular space and then the cutting balloon is removed from the pathway in the extravascular space prior to inserting the stent graft assembly into the expanded extravascular space.
  • an occluding device such as an occluding balloon, above the site of the endovascular bypass to reduce bleed out.
  • Stent framework 230 may be positioned between inner graft portion 240 and outer graft portion 250 .
  • Stent framework 230 may be made from a wide variety of medical implantable materials such as stainless steel, nitinol, tantalum, nickel, titanium, aluminum, polymeric materials, MP35N, stainless steel, titanium ASTM F63-83 Grade 1, niobium, high carat gold K 19-22, combinations of the above, and the like.
  • Inner graft portion 240 may be formed by applying a first polymer coating to a coating fixture having a flexible, non-stick surface.
  • the polymer coating may comprise a material including, but not limited to, a biodurable polycarbonate-based aromatic or aliphatic urethane, other urethanes or polyurethanes, polylactide (PLA), poly-l-lactic acid (PLLA), polyglycolic acid (PGA) polymer, poly (e-caprolactone) (PCL), polyacrylates, polymethacrylates, polycaprolactone (PCL), polymethylmethacrylate (PMMA), combinations and/or copolymers of the above, and the like.
  • the specific polymer, polymer combinations, or copolymers used may be adjusted as required by the specific needs of the medical device and the therapeutic agents delivered by the device.
  • Outer graft portion 250 may be formed by applying a second polymer coating that conjoins with inner graft portion 240 to encapsulate the stent framework.
  • the inner and outer graft portions may comprise the same or different polymers.
  • the two graft portions may conjoin by, for example, the second polymer coating adhering to the first polymer coating or by the second polymer coating melding with the first polymer coating to form a unitary structure.
  • the stent framework is encapsulated, meaning fully enclosed, by the conjoined graft portions.
  • a therapeutic agent may be included in one, both, or neither of the graft portions.
  • the inner and outer graft portions may include the same therapeutic agent, or inner graft portion 240 may include a first therapeutic agent, while outer graft portion 250 includes a second therapeutic agent.
  • FIG. 3 A flowchart of the steps of a method of providing an endovascular bypass between a main vessel and a branch vessel, in accordance with the present invention, is illustrated in FIG. 3 at 300 .
  • an elastic, e.g. shape-memory, needle is inserted in the vasculature adjacent an ostium via a catheter.
  • the needle is hollow with the internal diameter sized to carry a guidewire within the needle.
  • the guidewire is delivered through the needle during or following positioning of the needle.
  • the inner diameter of the needle may be sized to fit as large a guidewire as possible to maximize the strength of the guidewire for inserting a stent or stent graft over the guidewire.
  • Endovascular approaches to the vasculature are known in the art and frequently involve threading a tubular device such as a catheter through the vasculature.
  • main vessel is defined broadly to encompass any vessel of the body other than a branch vessel (defined below).
  • the main vessel may be any vessel of the body other than the branch vessel.
  • the main vessel is the aorta.
  • branch vessel is intended to identify the vessel with the ostium that will be occluded. However, use of these terms is not intended to limit the scope of the disclosure, and, instead, these terms are used to assist in an understanding of the disclosure.
  • the term “branch vessel” as used herein is defined broadly as any vessel other than a main vessel, or a location of the same vessel other than the location called the main vessel.
  • the term “branch vessel” is used in an effort to distinguish between the vessels, or locations of a single vessel, that form the ostium to be bypassed endovascularly. Any branch vessel may be used. In one embodiment, the branch vessel is a renal artery.
  • the needle is extended through the branch vessel wall.
  • the needle is extended through the sheath, as illustrated in FIGS. 1A, 1B , and IC.
  • the needle is carried through the catheter with the needle restrained from its shape-memory, preset arc shaped, unconstrained configuration, positioned within the sheath.
  • the needle extends through the extravascular space between the branch vessel and the main vessel, and at step 330 , the needle extends through the extravascular space.
  • the needle creates a tunnel or passage through the extravascular space.
  • an isolation device Prior to extending the needle through the branch vessel wall, an isolation device may be utilized to reduce the presence of blood in the area of the incision.
  • An isolation device is known to those of skill in the art, including isolation devices with a vacuum pump to further clear the vessel of blood in the area where the incision will be made.
  • an occluding balloon as known in the art, may be deployed upstream from the incision site to reduce blood flow.
  • FIG. 4A illustrates the needle deployed through the sidewall of the branch vessel 460 and main vessel 450 .
  • the main vessel is located by known imaging techniques.
  • the needle retracts, leaving the guidewire, and in step 350 , the needle is retracted from the main vessel, leaving the guidewire disposed within the vessel.
  • the needle creates a bypass pathway or tunnel between the main and branch vessels.
  • FIG. 4B illustrates the guidewire 465 disposed within the main vessel 450 and threaded through the extravascular space. Bleed out may be reduced with cautery devices, as known in the art.
  • a bypass stent graft is inserted along the guidewire to provide a pathway.
  • FIG. 4C illustrates the bypass stent graft prior to deployment disposed within the bypass pathway or tunnel 470 in the extravascular space.
  • the bypass stent graft includes a balloon expansion device that is expanded within the bypass stent graft at step 370 to expand the inserted stent graft in the extravascular space, thereby creating a larger pathway.
  • the bypass stent graft deployed in step 370 may be any appropriate stent graft device.
  • the bypass stent graft may be as illustrated in FIG. 2 . It is possible that the balloon expansion device will be insufficient to expand the extravascular space, and a cutting balloon may be inserted to assist in expansion of the extravascular space.
  • FIG. 4D illustrates the bypass stent graft inflated within the bypass pathway or tunnel 470 in the extravascular space, with the balloon expansion device expanded within the bypass stent graft.
  • a separate balloon expansion device is inserted over the guidewire to enlarge the extravascular path in the event that the conduit left by the needle is too small to insert the stent graft bypass.
  • the balloon may be a cutting balloon, or the balloon may present a substantially smooth exterior surface. The balloon expansion device is removed prior to inserting the bypass stent graft over the guidewire.
  • the bypass stent graft can be configured with an oversized and flared end surface 515 , as seen in FIG. 5A , configured so that blood pressure pushes the flared end surface against an interior surface of the vessel, creating a seal.
  • the bypass stent graft can be configured with at least one barbed surface 516 configured so that the barbed surface maintains the bypass stent graft in a position, as illustrated in FIG. 5B .
  • the barbed surface contributes to formation of a thrombus and may assist in formation of a seal between the surface of the bypass stent graft and the vessel wall.
  • a magnetic anastomosis device e.g.
  • a device available from Ventrica, Inc. of Fremont, Calif. is used to attach the bypass stent graft to the main and branch vessels.
  • Magnetic anastomosis devices may be beneficial in reducing the number of sutures needed to reduce bleed out and secure the bypass stent graft.
  • Magnetic anastomosis devices are self-seeking and self-aligning to connect blood vessels with their branches.
  • the ends of the bypass stent graft are sutured to the vessel walls, using an endoluminal suturing device, as known to those of skill in the art.
  • FIG. 4E illustrates an occluding device 480 deployed in position in the branch vessel between the ostium of the bypass stent graft and the main vessel.
  • An occluding device is known in the art.
  • This process is repeated for an opposing branch artery where there are two side branches, such as a renal artery.
  • a main vessel stent graft is inserted in the main vessel proximate the opening created by the needle.
  • FIG. 4F illustrates the main vessel stent graft 490 deployed in position within the main vessel.
  • the main vessel stent graft may be any appropriate stent graft, such as, for example, the stent graft illustrated in FIG. 2 .
  • bypass of the ostium between the main and branch vessels has been created with an endovascular approach.
  • a bypass has been created, thus avoiding, for example, an ostial aneurysm, with blood flow maintained to the branch vessel via the bypass stent graft, and maintained through the main vessel via the main vessel stent graft.
  • FIG. 6 illustrates a bypass of the ostium between the aorta and renal arteries.
  • stent graft 690 is in position, with bypass stent grafts 680 positioned between the aorta and renal arteries.
  • Occluding devices 685 are positioned to occlude blood flow and prevent blood flow from the bypass stent grafts into the aortic aneurysm.
  • FIG. 7 illustrates a bypass stent graft deployed at the ostium created at the intersection of the common iliac artery and the internal and external branches of the iliac artery.
  • the internal iliac branch 705 is occluded by an occluder 710
  • the bypass stent graft 725 is deployed in the common iliac artery 715 and through the external iliac artery 725 .
  • FIG. 8 illustrates a bypass stent graft deployed at the ostium created at the intersection of the aorta and celiac and superior mesenteric arteries.
  • the celiac artery 830 is occluded with an occluder 810 with a bypass stent graft 835 extending from the celiac artery into the superior mesenteric artery 840 .
  • a main stent graft 825 is disposed in the aorta 815 , so that blood flows through the main stent graft, into the superior mesenteric artery 840 and with blood flow through the bypass stent graft 835 into the celiac artery 830 .
  • FIGS. 9A-9C illustrate additional embodiments of uses for the bypass stent graft.
  • the aortic arch 950 is illustrated with a bypass stent graft extending from the left carotid artery 955 to the left subclavian artery 960 with the left subclavian artery occluded, and a main stent graft 965 deployed within the aorta.
  • FIG. 9B illustrates an embodiment where the left carotid and left subclavian arteries are bypassed.
  • a bypass stent graft extends from the brachian cephalic artery 970 to the left carotid artery 955
  • another bypass stent graft extends from the left carotid artery 955 to the left subclavian artery 960 .
  • the left carotid and left subclavian arteries 955 , 960 are occluded near their ostiums with the aorta, and a main stent graft 965 is deployed in the aorta.
  • FIG. 9C illustrates an embodiment where the brachian cephalic, left carotid, and left subclavian arteries 970 , 955 , 960 are bypassed near their ostiums with the aorta.
  • a bypass stent graft extends from the aorta to the brachian cephalic artery 970 , and the brachian cephalic artery 970 is occluded near its ostium with the aorta.
  • Another bypass stent graft extends from the brachian cephalic artery 970 to the left carotid artery 955 , with the left carotid artery 955 occluded near its ostium with the aorta.
  • bypass stent graft extends from the left carotid artery 955 to the left subclavian artery 960 , and the left subclavian artery 960 is occluded near its ostium with the aorta.
  • a stent graft extends from the aortic-brachian cephalic bypass stent graft to beyond the occluded left subclavian artery.
  • a system for treating an ostial aneurysm includes a catheter and a retractable shape-memory needle carried within the catheter and covered with a sheath.
  • the needle is a hollow needle with the internal diameter sized to carry the guidewire within the needle.
  • FIG. 1A illustrates the needle 110 carried within catheter 105 , as well as sheath 120 .
  • the needle releasably carries a guidewire, as shown in FIG. 1B .
  • the needle When the needle is positioned adjacent an ostium in a branch vessel, as seen in FIG. 5A , the needle is extended to deploy the needle to a predetermined shape and puncture through a sidewall of the branch vessel, through the extravascular space, and through a sidewall of the main vessel. After deployment, the needle releases the guidewire and the needle is retracted to allow placement of a bypass stent graft in the extravascular space between the branch and main vessels.
  • Another embodiment according to the invention provides a system for treating a vascular condition and includes a catheter, stent graft, and a shape memory needle releasably carrying a guidewire disposed within the needle.
  • Stent grafts used herein comprise any appropriate, biocompatible material.
  • the graft comprises polyester.
  • the graft comprises venous material.
  • the graft comprises ePTFE, silicone, polyurethane, or any combination of the above.
  • the stent graft may include a stent device, and the stent device may be coated with a therapeutic agent.
  • the needle may be radio-opaque, and may be coated with a contrast material to augment radio-opacity.
  • the stent comprises any appropriate material, such as stainless steel or nitinol.
  • the stent comprises tantalum, MP35N alloy, platinum, titanium, a chromium-based alloy, a suitable biocompatible alloy, a suitable biocompatible polymer, or combinations thereof.
  • ostium herein is the opening of a smaller branch into a larger main vessel. Locations “adjacent” an ostium are also to be construed broadly, such that activity at a location “adjacent” an ostium affects blood flow around the ostium. Therefore, for example, inserting a shape-memory needle adjacent an ostium via a catheter means placing the needle in a location wherein the needle placement affects blood flow around the ostium.
  • bypass could be obtained by inserting the bypass stent graft from the main vessel through the extravascular space and into the branch vessel.
  • Such an approach may be slightly more difficult in practice, as targeting the branch vessel from the extravascular space will require greater precision as the branch vessel may have a smaller profile than the main vessel.

Abstract

The invention provides a method of providing an endovascular bypass. The method includes the steps of inserting an elastic needle carrying a guidewire adjacent an ostium via a catheter and extending the needle through a branch vessel wall. The method continues by extending the needle through the extravascular space and inserting the needle through a main vessel wall to create an opening. The needle is retracted, leaving the guidewire in place. A bypass stent graft is inserted along the guidewire to provide a pathway between the branch vessel and the main vessel, and the inserted bypass stent graft is expanded. The branch vessel is occluded between the ostium of the bypass stent graft and the main vessel, and a main stent graft is inserted in the main vessel proximate the opening in the main vessel wall.

Description

    RELATED APPLICATIONS
  • This application claims the benefit of U.S. Provisional Application 60/574503 filed on May 26, 2004.
  • TECHNICAL FIELD
  • This invention relates generally to biomedical devices that are used for treating vascular conditions. More specifically, the invention relates to a method for endovascular bypass stent graft delivery.
  • BACKGROUND OF THE INVENTION
  • Stents are generally cylindrical-shaped devices that are radially expandable to hold open a segment of a vessel or other anatomical lumen after implantation into the body lumen.
  • Various types of stents are in use, including expandable and self-expanding stents. Expandable stents generally are conveyed to the area to be treated on balloon catheters or other expandable devices. For insertion, the stent is positioned in a compressed configuration along the delivery device, for example crimped onto a balloon that is folded or otherwise wrapped about a guidewire that is part of the delivery device. After the stent is positioned across the lesion, it is expanded by the delivery device, causing the diameter to expand. For a self-expanding stent, commonly a sheath is retracted, allowing expansion of the stent.
  • Stents may be used in conjunction with a graft. When the graft is used to deliver drugs or other therapeutic agents for medical therapeutic applications, 100% coverage of the portion of the vessel in direct contact with the graft is possible. The graft component of a stent graft may also aid in minimizing thrombosis, preventing embolic events, and minimizing contact between the fissured plaque and the hematological elements in the bloodstream.
  • In addition, the graft component makes the device suitable for use in treating aneurysms. An aneurysm is a bulge or sac that forms in the wall of a blood vessel. The force of normal blood pressure in the aneurysm may cause the vessel to rupture. Aneurysms result from many causes that weaken the vessel wall, including but not limited to heredity, trauma, or disease.
  • A number of methods and devices have been developed for treating aneurysms. A standard treatment is surgery, which is performed to bypass the section of the vessel where the aneurysm has formed. Some patients are not good candidates for such open surgery, and, due to the highly invasive nature of the open procedure, other patients may not wish to undergo the treatment.
  • An alternative treatment is a technique known as endovascular stent grafting. In this procedure, a stent graft is placed inside the vessel affected by the aneurysm to bypass the weakened vessel wall, thereby preventing rupture of the aneurysm. Like stents, stent grafts are delivered to the area to be treated using balloon catheters or other expandable devices and may deliver one or more therapeutic agents.
  • Placing stent grafts at the ostia of vessels has been difficult due to placement restrictions—placing a stent graft at an ostium requires that the stent graft be close to but not overlapping the ostium to maintain the desired blood flow between the main vessel and a branch vessel. Another approach is to provide a fenestration in the side of a graft at the branching ostium, in some instances, a branching tube to seal to the branch has been proposed. An exemplary approach is disclosed by Wisselink in U.S. Pat. No. 6,428,565. However, the Wisselink reference requires customizing the stent graft to correspond to the vessel anatomy ensuring the seal between the graft devices.
  • Therefore, it would be desirable to have a stent graft system that overcomes the aforementioned and other disadvantages.
  • SUMMARY OF THE INVENTION
  • One aspect according to the invention is a method of providing an endovascular bypass. The method includes inserting an elastic, e.g. shape-memory, needle adjacent an ostium via a catheter and extending the needle through a branch vessel wall. The needle is extended through an extravascular space and through a main vessel wall to create an opening. A guidewire is delivered via the needle. The needle is retracted, leaving the guidewire in place, and a bypass stent graft is inserted along the guidewire through the extravascular space between the branch vessel and the main vessel. The bypass stent graft is expanded and the branch vessel occluded between the opening of the bypass stent graft in the branch vessel and the main vessel. The method further includes inserting a main vessel stent graft in the main vessel proximate the opening of the bypass stent graft into the main vessel wall.
  • Another aspect according to the invention provides a system for treating an ostial aneurysm. The system includes a catheter including a retractable elastic needle carried within the catheter and covered with a sheath, wherein when the needle is positioned adjacent the ostium in a branch vessel, the needle deploys into a predetermined shape and punctures through a sidewall of the branch vessel through the extravascular space and through a sidewall of the main vessel, a guidewire is delivered via the needle, and the needle is retracted to allow placement of a bypass stent graft.
  • Yet another aspect according to the invention provides a system for treating a vascular condition. The system includes a catheter, a stent graft, and an elastic needle releasably carrying a guidewire disposed within the needle.
  • The aforementioned and other features and advantages in embodiments according to the invention will become further apparent from the following detailed description embodiments, read in conjunction with the accompanying drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIGS. 1A, 1B, 1C, and 1D are views of one embodiment of a needle assembly, in accordance with the present invention;
  • FIG. 2 is a view of one embodiment of a stent-graft assembly, in accordance with the present invention;
  • FIG. 3 is a flow chart illustrating the steps of a method for providing an endovascular bypass, in accordance with the present invention;
  • FIGS. 4A, 4B, 4C, 4D, 4E and 4F are schematic cross sectional views of a vascular structure, illustrating in situ the steps of the method described in FIGS. 1A, 1B, 1C, and 1D;
  • FIGS. 5A and 5B are schematic cross sectional views of other embodiments of stent graft assemblies, in accordance with the present invention;
  • FIG. 6 is a schematic cross sectional view of a bypass of an ostium with a bypass stent graft and a main stent graft in accordance with one aspect of the present invention;
  • FIG. 7 is a schematic cross sectional view of a bypass of the ostium of the common iliac artery with the internal and external branches of the artery with a bypass stent graft and a main stent graft in accordance with the present invention;
  • FIG. 8 is a schematic cross sectional view of a bypass of the ostium of the aorta with the celiac artery and superior mesenteric artery with a bypass stent graft and a main stent graft in accordance with the present invention; and
  • FIGS. 9A-9C are schematic cross sectional views of bypasses of arteries of the aortic arch with a bypass stent graft and a main stent graft in accordance with the present invention.
  • DETAILED DESCRIPTION
  • One embodiment of the invention comprises a needle system 100 as illustrated at FIGS. 1A, 1B, 1C and 1D. The system may be used to treat a vascular condition. For example, needle system 100 may be used to treat an ostial encroaching aneurysm. FIG. 1A illustrates needle system 100 prior to deployment. Needle system 100 includes needle 110 carried within a retractable sheath 120. Needle 110 and sheath 120 are delivered through a catheter 105, which is shown only in FIG. 1A.
  • Needle 110 is a curved needle comprising a shape-memory material. In one embodiment, needle 110 comprises nitinol. In other embodiments, needle 110 comprises tantalum, MP35N alloy, platinum, titanium, a chromium-based alloy, a suitable biocompatible alloy, a suitable biocompatible polymer, or combinations thereof. Prior to deployment, needle 110 is restrained in a substantially straight configuration by sheath 120.
  • FIG. 1B illustrates needle system 100 during deployment. As shown, while sheath 120 is held stationary, the needle is extended, allowing needle 110 to partially resume its preset shape. FIG. 1C illustrates needle system 100 in a deployed configuration. Needle 110 has assumed its preset shape-memory configuration. In one embodiment, the preset shape is an arc or curved shape.
  • Needle 110 is hollow with the internal diameter sized to carry a guidewire 130 within the needle, as seen in FIG. 1D. In one technique, the needle carries guidewire 130. In another embodiment, guidewire 130 is delivered through needle 110 during or following positioning of the needle.
  • Catheter 105 may carry a stent graft and may be a system such as system 200 illustrated in FIG. 2. System 200 comprises a catheter 210 and a stent graft assembly 220 operably coupled to the catheter. The coupling of stent graft assembly 220 to catheter 210 comprises any known technique for securing a stent graft to a delivery catheter. In an example, the stent graft is crimped to the catheter, while in other examples, heat-sensitive adhesives are used. Stent graft
  • assembly 220 includes a stent framework 230, an inner graft portion 240, and an outer graft portion 250. The stent graft assembly delivers a therapeutic agent, in one embodiment.
  • Catheter 210 may include a balloon to expand the stent graft as well as increase the size of a conduit or pathway (as illustrated in FIG. 4D below) to make it easier to pass the stent graft, or it may include a sheath that retracts to allow expansion of a self-expanding stent. Both types of catheter are well known in the art. Stent graft assembly 220 is shown coupled to catheter 210 for delivery within a vessel. The balloon may be any known balloon, and in some embodiments, the balloon is a cutting balloon, in the event the conduit left by the needle is too small to pass the stent graft system. Embodiments using a cutting balloon require that the stent graft assembly 220 is inserted only after the cutting balloon is removed from the area where deployment of the cutting balloon could impact upon deployment of the stent graft. Thus, embodiments using a cutting balloon may require operation of at least two balloons—a first cutting balloon to expand the pathway created by a needle, and a second balloon to expand the stent graft. Those of skill in the art will recognize that the balloon operable to expand the stent graft assembly could be replaced by a self-expanding stent, as known. Thus, the cutting balloon is expanded within the extravascular space to expand the pathway through the extravascular space and then the cutting balloon is removed from the pathway in the extravascular space prior to inserting the stent graft assembly into the expanded extravascular space. Further, in operation of the endovascular bypass disclosed herein, it may be desirable to operate an occluding device, such as an occluding balloon, above the site of the endovascular bypass to reduce bleed out.
  • One configuration is for stent framework 230 to be positioned between inner graft portion 240 and outer graft portion 250. Stent framework 230 may be made from a wide variety of medical implantable materials such as stainless steel, nitinol, tantalum, nickel, titanium, aluminum, polymeric materials, MP35N, stainless steel, titanium ASTM F63-83 Grade 1, niobium, high carat gold K 19-22, combinations of the above, and the like.
  • Inner graft portion 240 may be formed by applying a first polymer coating to a coating fixture having a flexible, non-stick surface. The polymer coating may comprise a material including, but not limited to, a biodurable polycarbonate-based aromatic or aliphatic urethane, other urethanes or polyurethanes, polylactide (PLA), poly-l-lactic acid (PLLA), polyglycolic acid (PGA) polymer, poly (e-caprolactone) (PCL), polyacrylates, polymethacrylates, polycaprolactone (PCL), polymethylmethacrylate (PMMA), combinations and/or copolymers of the above, and the like. The specific polymer, polymer combinations, or copolymers used may be adjusted as required by the specific needs of the medical device and the therapeutic agents delivered by the device.
  • Outer graft portion 250 may be formed by applying a second polymer coating that conjoins with inner graft portion 240 to encapsulate the stent framework. The inner and outer graft portions may comprise the same or different polymers. The two graft portions may conjoin by, for example, the second polymer coating adhering to the first polymer coating or by the second polymer coating melding with the first polymer coating to form a unitary structure. The stent framework is encapsulated, meaning fully enclosed, by the conjoined graft portions.
  • A therapeutic agent may be included in one, both, or neither of the graft portions. The inner and outer graft portions may include the same therapeutic agent, or inner graft portion 240 may include a first therapeutic agent, while outer graft portion 250 includes a second therapeutic agent.
  • A flowchart of the steps of a method of providing an endovascular bypass between a main vessel and a branch vessel, in accordance with the present invention, is illustrated in FIG. 3 at 300.
  • At step 310, an elastic, e.g. shape-memory, needle is inserted in the vasculature adjacent an ostium via a catheter. The needle is hollow with the internal diameter sized to carry a guidewire within the needle. The guidewire is delivered through the needle during or following positioning of the needle. The inner diameter of the needle may be sized to fit as large a guidewire as possible to maximize the strength of the guidewire for inserting a stent or stent graft over the guidewire.
  • Endovascular approaches to the vasculature are known in the art and frequently involve threading a tubular device such as a catheter through the vasculature.
  • The term “main vessel” is defined broadly to encompass any vessel of the body other than a branch vessel (defined below). The main vessel may be any vessel of the body other than the branch vessel. In one embodiment, the main vessel is the aorta.
  • The term “branch vessel” is intended to identify the vessel with the ostium that will be occluded. However, use of these terms is not intended to limit the scope of the disclosure, and, instead, these terms are used to assist in an understanding of the disclosure. The term “branch vessel” as used herein is defined broadly as any vessel other than a main vessel, or a location of the same vessel other than the location called the main vessel. The term “branch vessel” is used in an effort to distinguish between the vessels, or locations of a single vessel, that form the ostium to be bypassed endovascularly. Any branch vessel may be used. In one embodiment, the branch vessel is a renal artery.
  • At step 320, the needle is extended through the branch vessel wall. In order to extend the needle through the branch vessel wall, the needle is extended through the sheath, as illustrated in FIGS. 1A, 1B, and IC. Thus, during deployment of the needle, the needle is carried through the catheter with the needle restrained from its shape-memory, preset arc shaped, unconstrained configuration, positioned within the sheath. As the needle extends through the branch vessel wall, the needle extends through the extravascular space between the branch vessel and the main vessel, and at step 330, the needle extends through the extravascular space. During step 330, the needle creates a tunnel or passage through the extravascular space.
  • Prior to extending the needle through the branch vessel wall, an isolation device may be utilized to reduce the presence of blood in the area of the incision. An isolation device is known to those of skill in the art, including isolation devices with a vacuum pump to further clear the vessel of blood in the area where the incision will be made. In another example, an occluding balloon, as known in the art, may be deployed upstream from the incision site to reduce blood flow.
  • At step 340, the needle is inserted through a main vessel wall to create an opening. FIG. 4A illustrates the needle deployed through the sidewall of the branch vessel 460 and main vessel 450. The main vessel is located by known imaging techniques. After creating the opening through the main vessel, the needle retracts, leaving the guidewire, and in step 350, the needle is retracted from the main vessel, leaving the guidewire disposed within the vessel. The needle creates a bypass pathway or tunnel between the main and branch vessels. FIG. 4B illustrates the guidewire 465 disposed within the main vessel 450 and threaded through the extravascular space. Bleed out may be reduced with cautery devices, as known in the art.
  • At step 360, a bypass stent graft is inserted along the guidewire to provide a pathway. FIG. 4C illustrates the bypass stent graft prior to deployment disposed within the bypass pathway or tunnel 470 in the extravascular space. In one embodiment, the bypass stent graft includes a balloon expansion device that is expanded within the bypass stent graft at step 370 to expand the inserted stent graft in the extravascular space, thereby creating a larger pathway. The bypass stent graft deployed in step 370 may be any appropriate stent graft device. For example, the bypass stent graft may be as illustrated in FIG. 2. It is possible that the balloon expansion device will be insufficient to expand the extravascular space, and a cutting balloon may be inserted to assist in expansion of the extravascular space.
  • FIG. 4D illustrates the bypass stent graft inflated within the bypass pathway or tunnel 470 in the extravascular space, with the balloon expansion device expanded within the bypass stent graft. In one technique, prior to inserting the bypass stent graft, a separate balloon expansion device is inserted over the guidewire to enlarge the extravascular path in the event that the conduit left by the needle is too small to insert the stent graft bypass. The balloon may be a cutting balloon, or the balloon may present a substantially smooth exterior surface. The balloon expansion device is removed prior to inserting the bypass stent graft over the guidewire.
  • The bypass stent graft can be configured with an oversized and flared end surface 515, as seen in FIG. 5A, configured so that blood pressure pushes the flared end surface against an interior surface of the vessel, creating a seal. In another embodiment, the bypass stent graft can be configured with at least one barbed surface 516 configured so that the barbed surface maintains the bypass stent graft in a position, as illustrated in FIG. 5B. In embodiments having a barbed surface, the barbed surface contributes to formation of a thrombus and may assist in formation of a seal between the surface of the bypass stent graft and the vessel wall. In another embodiment, a magnetic anastomosis device, e.g. a device available from Ventrica, Inc. of Fremont, Calif., is used to attach the bypass stent graft to the main and branch vessels. Magnetic anastomosis devices may be beneficial in reducing the number of sutures needed to reduce bleed out and secure the bypass stent graft. Magnetic anastomosis devices are self-seeking and self-aligning to connect blood vessels with their branches. In yet another example, the ends of the bypass stent graft are sutured to the vessel walls, using an endoluminal suturing device, as known to those of skill in the art.
  • At step 380, the branch vessel is occluded between the ostium of the bypass stent graft in the branch vessel and the main vessel. FIG. 4E illustrates an occluding device 480 deployed in position in the branch vessel between the ostium of the bypass stent graft and the main vessel. An occluding device is known in the art.
  • This process is repeated for an opposing branch artery where there are two side branches, such as a renal artery.
  • At step 390, a main vessel stent graft is inserted in the main vessel proximate the opening created by the needle. FIG. 4F illustrates the main vessel stent graft 490 deployed in position within the main vessel. The main vessel stent graft may be any appropriate stent graft, such as, for example, the stent graft illustrated in FIG. 2.
  • Those of ordinary skill in the art will recognize that a bypass of the ostium between the main and branch vessels has been created with an endovascular approach. A bypass has been created, thus avoiding, for example, an ostial aneurysm, with blood flow maintained to the branch vessel via the bypass stent graft, and maintained through the main vessel via the main vessel stent graft.
  • FIG. 6 illustrates a bypass of the ostium between the aorta and renal arteries. As illustrated in FIG. 6, stent graft 690 is in position, with bypass stent grafts 680 positioned between the aorta and renal arteries. Occluding devices 685 are positioned to occlude blood flow and prevent blood flow from the bypass stent grafts into the aortic aneurysm.
  • FIG. 7 illustrates a bypass stent graft deployed at the ostium created at the intersection of the common iliac artery and the internal and external branches of the iliac artery. As shown in FIG. 7, the internal iliac branch 705 is occluded by an occluder 710, and the bypass stent graft 725 is deployed in the common iliac artery 715 and through the external iliac artery 725.
  • FIG. 8 illustrates a bypass stent graft deployed at the ostium created at the intersection of the aorta and celiac and superior mesenteric arteries. As illustrated in FIG. 8, the celiac artery 830 is occluded with an occluder 810 with a bypass stent graft 835 extending from the celiac artery into the superior mesenteric artery 840. A main stent graft 825 is disposed in the aorta 815, so that blood flows through the main stent graft, into the superior mesenteric artery 840 and with blood flow through the bypass stent graft 835 into the celiac artery 830.
  • FIGS. 9A-9C illustrate additional embodiments of uses for the bypass stent graft. In FIG. 9A, the aortic arch 950 is illustrated with a bypass stent graft extending from the left carotid artery 955 to the left subclavian artery 960 with the left subclavian artery occluded, and a main stent graft 965 deployed within the aorta.
  • FIG. 9B illustrates an embodiment where the left carotid and left subclavian arteries are bypassed. A bypass stent graft extends from the brachian cephalic artery 970 to the left carotid artery 955, and another bypass stent graft extends from the left carotid artery 955 to the left subclavian artery 960. The left carotid and left subclavian arteries 955, 960 are occluded near their ostiums with the aorta, and a main stent graft 965 is deployed in the aorta.
  • FIG. 9C illustrates an embodiment where the brachian cephalic, left carotid, and left subclavian arteries 970, 955, 960 are bypassed near their ostiums with the aorta. A bypass stent graft extends from the aorta to the brachian cephalic artery 970, and the brachian cephalic artery 970 is occluded near its ostium with the aorta. Another bypass stent graft extends from the brachian cephalic artery 970 to the left carotid artery 955, with the left carotid artery 955 occluded near its ostium with the aorta. Yet another bypass stent graft extends from the left carotid artery 955 to the left subclavian artery 960, and the left subclavian artery 960 is occluded near its ostium with the aorta. A stent graft extends from the aortic-brachian cephalic bypass stent graft to beyond the occluded left subclavian artery.
  • A system for treating an ostial aneurysm includes a catheter and a retractable shape-memory needle carried within the catheter and covered with a sheath. In one embodiment, the needle is a hollow needle with the internal diameter sized to carry the guidewire within the needle. FIG. 1A illustrates the needle 110 carried within catheter 105, as well as sheath 120. The needle releasably carries a guidewire, as shown in FIG. 1B. When the needle is positioned adjacent an ostium in a branch vessel, as seen in FIG. 5A, the needle is extended to deploy the needle to a predetermined shape and puncture through a sidewall of the branch vessel, through the extravascular space, and through a sidewall of the main vessel. After deployment, the needle releases the guidewire and the needle is retracted to allow placement of a bypass stent graft in the extravascular space between the branch and main vessels.
  • Another embodiment according to the invention provides a system for treating a vascular condition and includes a catheter, stent graft, and a shape memory needle releasably carrying a guidewire disposed within the needle.
  • Stent grafts used herein comprise any appropriate, biocompatible material. In one example, the graft comprises polyester. In one example, the graft comprises venous material. In other embodiments, the graft comprises ePTFE, silicone, polyurethane, or any combination of the above. The stent graft may include a stent device, and the stent device may be coated with a therapeutic agent. The needle may be radio-opaque, and may be coated with a contrast material to augment radio-opacity. The stent comprises any appropriate material, such as stainless steel or nitinol. In other examples, the stent comprises tantalum, MP35N alloy, platinum, titanium, a chromium-based alloy, a suitable biocompatible alloy, a suitable biocompatible polymer, or combinations thereof.
  • The word “ostium” herein is the opening of a smaller branch into a larger main vessel. Locations “adjacent” an ostium are also to be construed broadly, such that activity at a location “adjacent” an ostium affects blood flow around the ostium. Therefore, for example, inserting a shape-memory needle adjacent an ostium via a catheter means placing the needle in a location wherein the needle placement affects blood flow around the ostium.
  • Additionally, it should be noted that a bypass could be obtained by inserting the bypass stent graft from the main vessel through the extravascular space and into the branch vessel. Such an approach may be slightly more difficult in practice, as targeting the branch vessel from the extravascular space will require greater precision as the branch vessel may have a smaller profile than the main vessel.
  • While the embodiments of the invention have been disclosed herein, various changes and modifications can be made without departing from the spirit and scope of the invention.

Claims (23)

1. A method of providing an endovascular bypass, the method comprising:
inserting an elastic needle adjacent an ostium via a catheter;
extending the needle through a branch vessel wall;
extending the needle through an extravascular space;
inserting the needle through a main vessel wall to create an opening;
delivering a guidewire via the needle;
retracting the needle, leaving the guidewire in place;
inserting a bypass stent graft along the guidewire through the extravascular space between the branch vessel and the main vessel;
expanding the inserted bypass stent graft;
occluding the branch vessel between the bypass stent graft and the main vessel; and
inserting a main vessel stent graft in the main vessel proximate the opening in the main vessel wall.
2. The method of claim 1 wherein the needle comprises a shape-memory material.
3. The method of claim 2 wherein the needle comprises nitinol.
4. The method of claim 1 wherein the main vessel is the aorta.
5. The method of claim 1 wherein the branch vessel is a renal artery.
6. The method of claim 1 wherein the graft comprises a material selected from the group consisting of polyester, ePTFE, silicone, polyurethane, and venous material.
7. The method of claim 1 wherein the needle comprises a radio-opaque material or coating.
8. The method of claim 1 wherein the step of expanding the inserted stent graft comprises:
expanding a balloon expansion device.
9. The method of claim 1 wherein the step of inserting a bypass stent graft comprises:
operating a cutting balloon to expand the extravascular space; and
removing the cutting balloon from the extravascular space prior to inserting the bypass stent graft into the extravascular space.
10. The method of claim 1 wherein the stent graft is configured with an oversized and flared end surface configured so that blood pressure pushes the flared end surface against an interior surface of the vessel.
11. The method of claim 1 wherein the stent graft is configured with at least one barbed surface configured so that the barbed surface maintains the stent graft in a position.
12. The method of claim 1 further comprising:
Attaching the bypass stent graft to the main and branch vessels with a magnetic anastomosis device.
13. A system for treating an ostial aneurysm, the system comprising:
a catheter;
a retractable elastic needle carried within the catheter and covered with a sheath, wherein when the needle is positioned adjacent the ostium in a branch vessel, the needle deploys to a predetermined shape and punctures through a sidewall of the branch vessel and through a sidewall of the main vessel when the needle is extended, a guidewire is delivered via the needle, and the needle is retracted to allow placement of a bypass stent graft.
14. The system of claim 13 wherein the stent graft is configured with at least one barbed surface configured so that the barbed surface maintains the stent graft in a position.
15. The system of claim 13 wherein the stent graft is configured with an oversized and flared end surface configured so that blood pressure pushes the flared end surface against an interior surface of the vessel.
16. The system of claim 13 further comprising a balloon expansion device configured to expand in the extravascular space.
17. The system of claim 16 wherein the balloon expansion device comprises a cutting balloon.
18. The system of claim 13 wherein the needle comprises nitinol.
19. The system of claim 13 further comprising a magnetic anastomosis device configured to attach a bypass stent graft to a vessel.
20. A system for treating a vascular condition, the system comprising:
a catheter;
a stent graft; and
an elastic needle releasably carrying a guidewire disposed within the needle.
21. The system of claim 20 wherein the needle comprises nitinol.
22. The system of claim 22 further comprising a balloon expansion device configured to expand in the extravascular space.
23. The system of claim 22 further comprising a magnetic anastomosis device.
US10/891,397 2004-05-26 2004-07-14 Method for endovascular bypass stent graft delivery Abandoned US20050278013A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/891,397 US20050278013A1 (en) 2004-05-26 2004-07-14 Method for endovascular bypass stent graft delivery
PCT/US2005/015576 WO2005117751A1 (en) 2004-05-26 2005-05-04 Method for endovascular bypass stent graft delivery
US11/464,036 US7815656B2 (en) 2004-05-26 2006-08-11 Method for endovascular bypass stent graft delivery

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57450304P 2004-05-26 2004-05-26
US10/891,397 US20050278013A1 (en) 2004-05-26 2004-07-14 Method for endovascular bypass stent graft delivery

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/464,036 Division US7815656B2 (en) 2004-05-26 2006-08-11 Method for endovascular bypass stent graft delivery

Publications (1)

Publication Number Publication Date
US20050278013A1 true US20050278013A1 (en) 2005-12-15

Family

ID=34978697

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/891,397 Abandoned US20050278013A1 (en) 2004-05-26 2004-07-14 Method for endovascular bypass stent graft delivery
US11/464,036 Expired - Fee Related US7815656B2 (en) 2004-05-26 2006-08-11 Method for endovascular bypass stent graft delivery

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/464,036 Expired - Fee Related US7815656B2 (en) 2004-05-26 2006-08-11 Method for endovascular bypass stent graft delivery

Country Status (2)

Country Link
US (2) US20050278013A1 (en)
WO (1) WO2005117751A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080161839A1 (en) * 2005-01-25 2008-07-03 Nicast Ltd. Device and Method for Coronary Artery Bypass Procedure
WO2015085119A1 (en) * 2013-12-06 2015-06-11 Rox Medical, Inc. Methods, systems and devices for treating orthostatic intolerance
US20150174371A1 (en) * 2013-12-23 2015-06-25 Cook Medical Technologies Llc System for bypassing vascular occlusion having puncturing mechanism and method
US9114000B2 (en) 2011-03-14 2015-08-25 Cook Medical Technologies Llc Apparatus and methods to enhance bonding in endoluminal prostheses
EP2948097A4 (en) * 2013-01-23 2016-09-28 Rox Medical Inc Methods, systems and devices for treating cardiac arrhythmias
US10039905B1 (en) 2015-10-07 2018-08-07 Edwards Lifesciences Corporation Systems for deploying an expandable cardiac shunt
US10548710B2 (en) 2017-02-24 2020-02-04 The Cleveland Clinic Foundation Method and apparatus for time-differential deployment of an endovascular device within a body lumen

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7147661B2 (en) 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
US20110319976A1 (en) * 2010-01-27 2011-12-29 Sriram Iyer Device and method for preventing stenosis at an anastomosis site

Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5755775A (en) * 1995-01-23 1998-05-26 Schneider (Usa) Inc. Percutaneous stent-graft and method for delivery thereof
US5797935A (en) * 1996-09-26 1998-08-25 Interventional Technologies Inc. Balloon activated forced concentrators for incising stenotic segments
US5797920A (en) * 1996-06-14 1998-08-25 Beth Israel Deaconess Medical Center Catheter apparatus and method using a shape-memory alloy cuff for creating a bypass graft in-vivo
US5830222A (en) * 1995-10-13 1998-11-03 Transvascular, Inc. Device, system and method for intersititial transvascular intervention
US6004330A (en) * 1989-08-16 1999-12-21 Medtronic, Inc. Device or apparatus for manipulating matter
US6026814A (en) * 1997-03-06 2000-02-22 Scimed Life Systems, Inc. System and method for percutaneous coronary artery bypass
US6035856A (en) * 1997-03-06 2000-03-14 Scimed Life Systems Percutaneous bypass with branching vessel
US6071292A (en) * 1997-06-28 2000-06-06 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
US6190353B1 (en) * 1995-10-13 2001-02-20 Transvascular, Inc. Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
US6283983B1 (en) * 1995-10-13 2001-09-04 Transvascular, Inc. Percutaneous in-situ coronary bypass method and apparatus
US6283951B1 (en) * 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6290728B1 (en) * 1998-09-10 2001-09-18 Percardia, Inc. Designs for left ventricular conduit
US6302875B1 (en) * 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US6330884B1 (en) * 1997-11-14 2001-12-18 Transvascular, Inc. Deformable scaffolding multicellular stent
US6352543B1 (en) * 2000-04-29 2002-03-05 Ventrica, Inc. Methods for forming anastomoses using magnetic force
US6375615B1 (en) * 1995-10-13 2002-04-23 Transvascular, Inc. Tissue penetrating catheters having integral imaging transducers and their methods of use
US6428565B1 (en) * 1997-09-11 2002-08-06 Medtronic Ave, Inc. System and method for edoluminal grafting of bifurcated or branched vessels
US6432127B1 (en) * 1996-10-11 2002-08-13 Transvascular, Inc. Devices for forming and/or maintaining connections between adjacent anatomical conduits
US6508824B1 (en) * 2000-02-18 2003-01-21 Transvascular, Inc. Catheter-based methods for enlarging blood vessels to facilitate the formation of penetration tracts, fistulas and/or blood flow channels
US6517574B1 (en) * 2000-04-27 2003-02-11 Endovascular Technologies, Inc. System and method for endovascular aneurysm repair in conjunction with vascular stabilization
US6544230B1 (en) * 1998-03-31 2003-04-08 Transvascular, Inc. Catheters, systems and methods for percutaneous in situ arterio-venous bypass
US6561998B1 (en) * 1998-04-07 2003-05-13 Transvascular, Inc. Transluminal devices, systems and methods for enlarging interstitial penetration tracts
US6569145B1 (en) * 1999-03-25 2003-05-27 Transvascular, Inc. Pressure-controlled continuous coronary sinus occlusion device and methods of use
US6579311B1 (en) * 1996-02-02 2003-06-17 Transvascular, Inc. Method for interstitial transvascular intervention
US6602241B2 (en) * 2001-01-17 2003-08-05 Transvascular, Inc. Methods and apparatus for acute or chronic delivery of substances or apparatus to extravascular treatment sites
US6616675B1 (en) * 1996-02-02 2003-09-09 Transvascular, Inc. Methods and apparatus for connecting openings formed in adjacent blood vessels or other anatomical structures
US6726677B1 (en) * 1995-10-13 2004-04-27 Transvascular, Inc. Stabilized tissue penetrating catheters
US6843795B1 (en) * 1998-06-10 2005-01-18 Converge Medical, Inc. Anastomotic connector for sutureless anastomosis systems

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036702A (en) * 1997-04-23 2000-03-14 Vascular Science Inc. Medical grafting connectors and fasteners
WO2000033909A1 (en) 1998-12-09 2000-06-15 Cook Incorporated Hollow, curved, superelastic medical needle
US6638237B1 (en) * 1999-08-04 2003-10-28 Percardia, Inc. Left ventricular conduits and methods for delivery
US6854467B2 (en) * 2000-05-04 2005-02-15 Percardia, Inc. Methods and devices for delivering a ventricular stent
US6591559B2 (en) * 2001-04-03 2003-07-15 Victor Contreras Exterior wall sealing system
US7144421B2 (en) * 2003-11-06 2006-12-05 Carpenter Judith T Endovascular prosthesis, system and method

Patent Citations (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004330A (en) * 1989-08-16 1999-12-21 Medtronic, Inc. Device or apparatus for manipulating matter
US5755775A (en) * 1995-01-23 1998-05-26 Schneider (Usa) Inc. Percutaneous stent-graft and method for delivery thereof
US6726677B1 (en) * 1995-10-13 2004-04-27 Transvascular, Inc. Stabilized tissue penetrating catheters
US6231587B1 (en) * 1995-10-13 2001-05-15 Transvascular, Inc. Devices for connecting anatomical conduits such as vascular structures
US6375615B1 (en) * 1995-10-13 2002-04-23 Transvascular, Inc. Tissue penetrating catheters having integral imaging transducers and their methods of use
US6655386B1 (en) * 1995-10-13 2003-12-02 Transvascular, Inc. Transluminal method for bypassing arterial obstructions
US6660024B1 (en) * 1995-10-13 2003-12-09 Transvascular, Inc. Tissue penetrating catheters having integral imaging transducers and their methods of use
US6068638A (en) * 1995-10-13 2000-05-30 Transvascular, Inc. Device, system and method for interstitial transvascular intervention
US6283983B1 (en) * 1995-10-13 2001-09-04 Transvascular, Inc. Percutaneous in-situ coronary bypass method and apparatus
US6159225A (en) * 1995-10-13 2000-12-12 Transvascular, Inc. Device for interstitial transvascular intervention and revascularization
US6190353B1 (en) * 1995-10-13 2001-02-20 Transvascular, Inc. Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
US5830222A (en) * 1995-10-13 1998-11-03 Transvascular, Inc. Device, system and method for intersititial transvascular intervention
US6579311B1 (en) * 1996-02-02 2003-06-17 Transvascular, Inc. Method for interstitial transvascular intervention
US6616675B1 (en) * 1996-02-02 2003-09-09 Transvascular, Inc. Methods and apparatus for connecting openings formed in adjacent blood vessels or other anatomical structures
US5797920A (en) * 1996-06-14 1998-08-25 Beth Israel Deaconess Medical Center Catheter apparatus and method using a shape-memory alloy cuff for creating a bypass graft in-vivo
US5797935A (en) * 1996-09-26 1998-08-25 Interventional Technologies Inc. Balloon activated forced concentrators for incising stenotic segments
US6283951B1 (en) * 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6302875B1 (en) * 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US6432127B1 (en) * 1996-10-11 2002-08-13 Transvascular, Inc. Devices for forming and/or maintaining connections between adjacent anatomical conduits
US6253769B1 (en) * 1997-03-06 2001-07-03 Scimed Life Systems, Inc. Method for percutaneous coronary artery bypass
US6035856A (en) * 1997-03-06 2000-03-14 Scimed Life Systems Percutaneous bypass with branching vessel
US6026814A (en) * 1997-03-06 2000-02-22 Scimed Life Systems, Inc. System and method for percutaneous coronary artery bypass
US6071292A (en) * 1997-06-28 2000-06-06 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
US6491707B2 (en) * 1997-06-28 2002-12-10 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
US6428565B1 (en) * 1997-09-11 2002-08-06 Medtronic Ave, Inc. System and method for edoluminal grafting of bifurcated or branched vessels
US6330884B1 (en) * 1997-11-14 2001-12-18 Transvascular, Inc. Deformable scaffolding multicellular stent
US6544230B1 (en) * 1998-03-31 2003-04-08 Transvascular, Inc. Catheters, systems and methods for percutaneous in situ arterio-venous bypass
US6561998B1 (en) * 1998-04-07 2003-05-13 Transvascular, Inc. Transluminal devices, systems and methods for enlarging interstitial penetration tracts
US6843795B1 (en) * 1998-06-10 2005-01-18 Converge Medical, Inc. Anastomotic connector for sutureless anastomosis systems
US6290728B1 (en) * 1998-09-10 2001-09-18 Percardia, Inc. Designs for left ventricular conduit
US6569145B1 (en) * 1999-03-25 2003-05-27 Transvascular, Inc. Pressure-controlled continuous coronary sinus occlusion device and methods of use
US6508824B1 (en) * 2000-02-18 2003-01-21 Transvascular, Inc. Catheter-based methods for enlarging blood vessels to facilitate the formation of penetration tracts, fistulas and/or blood flow channels
US6517574B1 (en) * 2000-04-27 2003-02-11 Endovascular Technologies, Inc. System and method for endovascular aneurysm repair in conjunction with vascular stabilization
US6352543B1 (en) * 2000-04-29 2002-03-05 Ventrica, Inc. Methods for forming anastomoses using magnetic force
US6602241B2 (en) * 2001-01-17 2003-08-05 Transvascular, Inc. Methods and apparatus for acute or chronic delivery of substances or apparatus to extravascular treatment sites

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080161839A1 (en) * 2005-01-25 2008-07-03 Nicast Ltd. Device and Method for Coronary Artery Bypass Procedure
US9114000B2 (en) 2011-03-14 2015-08-25 Cook Medical Technologies Llc Apparatus and methods to enhance bonding in endoluminal prostheses
EP2948097A4 (en) * 2013-01-23 2016-09-28 Rox Medical Inc Methods, systems and devices for treating cardiac arrhythmias
US10448953B2 (en) 2013-01-23 2019-10-22 Rox Medical, Inc. Methods, systems and devices for treating cardiac arrhythmias
WO2015085119A1 (en) * 2013-12-06 2015-06-11 Rox Medical, Inc. Methods, systems and devices for treating orthostatic intolerance
US20150174371A1 (en) * 2013-12-23 2015-06-25 Cook Medical Technologies Llc System for bypassing vascular occlusion having puncturing mechanism and method
US10039905B1 (en) 2015-10-07 2018-08-07 Edwards Lifesciences Corporation Systems for deploying an expandable cardiac shunt
US10548710B2 (en) 2017-02-24 2020-02-04 The Cleveland Clinic Foundation Method and apparatus for time-differential deployment of an endovascular device within a body lumen

Also Published As

Publication number Publication date
US20070203565A1 (en) 2007-08-30
US7815656B2 (en) 2010-10-19
WO2005117751A1 (en) 2005-12-15

Similar Documents

Publication Publication Date Title
US5728131A (en) Coupling device and method of use
US7815656B2 (en) Method for endovascular bypass stent graft delivery
US5800521A (en) Prosthetic graft and method for aneurysm repair
US9744059B2 (en) Vascular implant
AU2002353807B2 (en) Endovascular aneurysm repair system
AU2007221953B2 (en) Intravascular deliverable stent for reinforcement of vascular abnormalities
US7674284B2 (en) Endoluminal graft
JP5220329B2 (en) Stent graft device
US20050049678A1 (en) Stent
US20060025844A1 (en) Reduced deployment force delivery device
JP2003245359A (en) Coated segment type stent
US9579103B2 (en) Percutaneous method and device to treat dissections
EP3917461A2 (en) Expandable luminal stents and methods of use
EP0836449B1 (en) Prosthetic graft for aneurysm repair
JP2009078172A (en) Endovascular aneurysm repair system
JP2019529008A (en) Systems and methods having stents and filling structures
US20200368010A1 (en) Percutaneous method and device to treat dissections

Legal Events

Date Code Title Description
AS Assignment

Owner name: MEDTRONIC VASCULAR, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RUST, MATTHEW;GANESAN, PREMA;HANSON, CURTIS;AND OTHERS;REEL/FRAME:015575/0552;SIGNING DATES FROM 20040615 TO 20040629

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION